FdaApplication

BLA 761269

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEisai, Incorporated
application_typeBLA
approval_date2023-01-06

Products (2)

ProductActive ingredientStrengthDosage form
LEQEMBILECANEMAB-IRMB500MG/5ML (100MG/ML)Injection
LEQEMBILECANEMAB-IRMB200MG/2ML (100MG/ML)Injection

2 products